NFκB activation has been shown to be increased in BPH samples progressing to disease-specific surgery and was associated with increased expression of 5α-reductase 2, increased androgen receptor expression, and increased cellular proliferation in vitro44,45, and TNF may drive this paradigm. The gene discussed is TNF; the disease is benign prostatic hyperplasia.